Latest ebit for BABYD: $-5.2M, below the sector sector average of $2.6T.
Get informed when a big investor buys or sells
+ FollowAs of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026
As of the most recent data (March 2026), BABYD shows a EBIT of $-5.2M. That compares with $-13M in the prior-year period — up 59.6% year over year. That is below the sector sector average of $2.6T. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, BABYD's EBIT is now $-5.2M (was $-13M) — a 59.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Else Nutrition Holdings is outperforming or lagging.
The its sector sector average EBIT is about $2.6T. Else Nutrition Holdings is at $-5.2M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how BABYD stacks up against individual peers as well.
Tracking BABYD's ebit over time shows whether Else Nutrition Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $-5.2M That compares with $-13M in the prior-year period — up 59.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has Else Nutrition Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-5.2M) with ownership activity and broader fundamentals.